Hyderabad-based Dr. Reddy’s Laboratories Ltd reported a second quarter consolidated revenue of Rs39.9 billion, up 11 per cent on the year.
Profit after tax was Rs. 7.2 billion for the quarter ended September 30, 2015, strong year-on-year growth of 26%, said the company.
Commenting on the results, Dr. Reddy’s co-chairman and CEO, GV Prasad said, “I am pleased with our performance for this quarter. We had robust sales growth across our markets of US, India and Europe, supported by new products that were launched in the last twelve months.
“Our investment in R&D remains at 11%, as we continue on our strategy of building an exciting pipeline of assets across our businesses. While satisfied with our performance, we are intensely focused on enhancing our quality management system and infrastructure to meet evolving global requirements and address the pending cGMP related matters at some of our facilities,” he said. fii-news.com
